相关实验视频

Updated: May 24, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

优化的脂质纳米颗粒能够在树突细胞中有效地进行CRISPR/Cas9介导的基因编辑,从而增强免疫疗法

Kuirong Mao^1,2,3, Huizhu Tan^1,3, Xiuxiu Cong^1,3

¹Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun 130061, China.

Acta pharmaceutica Sinica. B

|March 5, 2025

概括

这项研究优化了脂质纳米颗粒 (LNP) 以向树突细胞 (DC) 传递CRISPR/Cas9基因编辑. 这些纳米颗粒中的低胆固醇密度增强了基因编辑,导致免疫治疗中瘤生长抑制.

科学领域:

免疫学免疫学免疫学
基因治疗基因治疗
纳米技术纳米技术

背景情况:

树突细胞 (DCs) 对于免疫反应和免疫疗法至关重要.
在DC中进行CRISPR-Cas9基因编辑是有希望的,但面临着交付挑战.
脂质纳米粒子 (LNP) 已被用于基因传递,但其DC应用尚未得到充分研究.

研究的目的:

研究胆固醇在脂质辅助纳米颗粒 (BLAN) 中的作用,用于CRISPR/Cas9向DCs传递.
在树突细胞中优化BLAN以实现高效的基因编辑.
评估胆固醇调节的BLAN在癌症免疫治疗中的治疗潜力.

主要方法:

使用了BAMEA-O16B脂质辅助纳米颗粒 (BLAN) 进行CRISPR/Cas9传递.
研究了胆固醇密度对纳米粒子功能的影响 (mRNA吸收,内体逃生,gRNA释放).
给小鼠服用BLANmCas9/gPD-L1并评估PD-L1淘汰,cDC1激活,T细胞反应和瘤生长.

主要成果:

低胆固醇密度的BLAN显示DCs中的mRNA吸收和内体逃生优异.
通过低胆固醇的BLANs实现了单导向RNA的有效释放.
BLANmCas9/gPD-L1治疗导致传统树突细胞 (cDC) 中显著的PD-L1基因淘汰.
观察到增强的cDC1激活,T细胞刺激和大量的瘤生长抑制.

结论:

胆固醇密度对树突细胞中LNP介导的基因编辑疗效产生重大影响.
优化的BLAN为CRISPR/Cas9传递给癌症免疫治疗的DC提供了一个有希望的策略.
这种方法为治疗免疫相关疾病和增强抗瘤免疫提供了一个新的途径.

关键词:

这就是CRISPR/Cas9的作用.胆固醇密度胆固醇密度树突性细胞树突性细胞基因编辑基因编辑与免疫系统相关的疾病.免疫治疗是一种免疫疗法.脂质纳米颗粒的使用方法在PD-L1中.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...